https://www.gov.uk/government/collections/ministerial-gifts-hospitality-overseas-travel-and-meetings#2022<\/a><\/p> <\/p>
No specific assessment of the potential impact of changes to the Voluntary Scheme for Branded Medicines Pricing and Access rebate rate has been made. Changes to payment percentages reflects the Scheme working as intended to adjust for increased sales of branded medicines to the National Health Service. This will result in payment percentages at the rates projected when the Scheme was agreed with industry.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4423", "label" : {"_value" : "Biography information for Will Quince"}
}
, "answeringMemberConstituency" : {"_value" : "Colchester"}
, "answeringMemberPrinted" : {"_value" : "Will Quince"}
, "dateOfAnswer" : {"_value" : "2022-11-03", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "previousAnswerVersion" : {"_about" : "http://data.parliament.uk/resources/1536554/answer/previousversion/29183", "answeringMember" : {"_about" : "http://data.parliament.uk/members/4423", "label" : {"_value" : "Biography information for Will Quince"}
}
, "answeringMemberConstituency" : {"_value" : "Colchester"}
, "answeringMemberPrinted" : {"_value" : "Will Quince"}
}
, "questionFirstAnswered" : [{"_value" : "2022-11-03T18:15:17.74Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2022-10-26", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Voluntary Scheme for Branded Medicines Pricing and Access"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, what (a) meetings and (b) discussions he has with representatives of (i) pharmaceutical and (ii) life science companies on changes to the Voluntary Scheme for Branded Medicines Pricing and Access (VPAS); and what assessment he has made of the potential impact of changes to the VPAS rebate rate on foreign direct investment into UK life science R&D.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4124", "label" : {"_value" : "Biography information for Chi Onwurah"}
}
, "tablingMemberConstituency" : {"_value" : "Newcastle upon Tyne Central"}
, "tablingMemberPrinted" : [{"_value" : "Chi Onwurah"}
], "uin" : "72255"}
, {"_about" : "http://data.parliament.uk/resources/1536556", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1536556/answer", "answerText" : {"_value" : "
No specific assessment has been made.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4679", "label" : {"_value" : "Biography information for Neil O'Brien"}
}
, "answeringMemberConstituency" : {"_value" : "Harborough"}
, "answeringMemberPrinted" : {"_value" : "Neil O'Brien"}
, "dateOfAnswer" : {"_value" : "2022-11-03", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2022-11-03T17:49:51.323Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2022-10-26", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Life Expectancy: Newcastle upon Tyne"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, what assessment he has made of the implications for her policies of trends in the level of healthy life expectancy in Newcastle.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4124", "label" : {"_value" : "Biography information for Chi Onwurah"}
}
, "tablingMemberConstituency" : {"_value" : "Newcastle upon Tyne Central"}
, "tablingMemberPrinted" : [{"_value" : "Chi Onwurah"}
], "uin" : "72256"}
, {"_about" : "http://data.parliament.uk/resources/1536557", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1536557/answer", "answerText" : {"_value" : "
In September we announced \u2018Our plan for patients\u2019, which outlines how we will increase access to National Health Service mental health and eating disorder services, including in Newcastle. Through the NHS Long Term Plan, we are investing an additional £2.3 billion a year by 2023/24 to expand NHS mental health and eating disorder services for adults, children and young people in England, including in Newcastle.<\/p>
We will invest approximately £1 billion in community mental health care for adults with severe mental illness. including eating disorders, by 2023/24 and an additional £53 million per year in children and young people's community eating disorder services to increase capacity in the 70 community eating disorder teams.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4492", "label" : {"_value" : "Biography information for Maria Caulfield"}
}
, "answeringMemberConstituency" : {"_value" : "Lewes"}
, "answeringMemberPrinted" : {"_value" : "Maria Caulfield"}
, "dateOfAnswer" : {"_value" : "2022-11-02", "_datatype" : "dateTime"}
, "groupedQuestionUIN" : {"_value" : "72259"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2022-11-02T13:15:28.187Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2022-10-26", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Eating Disorders: Newcastle upon Tyne"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, what steps her Department is taking to help support young people with eating disorders in Newcastle.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4124", "label" : {"_value" : "Biography information for Chi Onwurah"}
}
, "tablingMemberConstituency" : {"_value" : "Newcastle upon Tyne Central"}
, "tablingMemberPrinted" : [{"_value" : "Chi Onwurah"}
], "uin" : "72257"}
, {"_about" : "http://data.parliament.uk/resources/1536559", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1536559/answer", "answerText" : {"_value" : "
In September we announced \u2018Our plan for patients\u2019, which outlines how we will increase access to National Health Service mental health and eating disorder services, including in Newcastle. Through the NHS Long Term Plan, we are investing an additional £2.3 billion a year by 2023/24 to expand NHS mental health and eating disorder services for adults, children and young people in England, including in Newcastle.<\/p>
We will invest approximately £1 billion in community mental health care for adults with severe mental illness. including eating disorders, by 2023/24 and an additional £53 million per year in children and young people's community eating disorder services to increase capacity in the 70 community eating disorder teams.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4492", "label" : {"_value" : "Biography information for Maria Caulfield"}
}
, "answeringMemberConstituency" : {"_value" : "Lewes"}
, "answeringMemberPrinted" : {"_value" : "Maria Caulfield"}
, "dateOfAnswer" : {"_value" : "2022-11-02", "_datatype" : "dateTime"}
, "groupedQuestionUIN" : {"_value" : "72257"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2022-11-02T13:15:28.263Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2022-10-26", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Mental Health Services: Newcastle upon Tyne"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, what steps his Department is taking to help support the (a) recruitment and (b) retention of mental health specialists in Newcastle.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4124", "label" : {"_value" : "Biography information for Chi Onwurah"}
}
, "tablingMemberConstituency" : {"_value" : "Newcastle upon Tyne Central"}
, "tablingMemberPrinted" : [{"_value" : "Chi Onwurah"}
], "uin" : "72259"}
, {"_about" : "http://data.parliament.uk/resources/1536560", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1536560/answer", "answerText" : {"_value" : "
This information is not held in the format requested.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4423", "label" : {"_value" : "Biography information for Will Quince"}
}
, "answeringMemberConstituency" : {"_value" : "Colchester"}
, "answeringMemberPrinted" : {"_value" : "Will Quince"}
, "dateOfAnswer" : {"_value" : "2022-10-31", "_datatype" : "dateTime"}
, "groupedQuestionUIN" : [{"_value" : "72370"}
, {"_value" : "72423"}
, {"_value" : "72496"}
], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2022-10-31T10:12:36.283Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2022-10-26", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Dental Services: Newcastle upon Tyne"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, how many children under the age of (a) four and (b) 11 were admitted to hospital for a tooth extraction due to decay in Newcastle in each of the last five years.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4124", "label" : {"_value" : "Biography information for Chi Onwurah"}
}
, "tablingMemberConstituency" : {"_value" : "Newcastle upon Tyne Central"}
, "tablingMemberPrinted" : [{"_value" : "Chi Onwurah"}
], "uin" : "72260"}
, {"_about" : "http://data.parliament.uk/resources/1524730", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1524730/answer", "answerText" : {"_value" : "
No recent assessment has been made. Changes to payment percentages reflects the Scheme working as intended to adjust for increased sales of branded medicines to the National Health Service. This will result in payment percentages at rates projected when the Scheme was agreed with industry.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4423", "label" : {"_value" : "Biography information for Will Quince"}
}
, "answeringMemberConstituency" : {"_value" : "Colchester"}
, "answeringMemberPrinted" : {"_value" : "Will Quince"}
, "dateOfAnswer" : {"_value" : "2022-10-27", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "previousAnswerVersion" : {"_about" : "http://data.parliament.uk/resources/1524730/answer/previousversion/27495", "answeringMember" : "http://data.parliament.uk/members/4320", "answeringMemberConstituency" : {"_value" : "Newark"}
, "answeringMemberPrinted" : {"_value" : "Robert Jenrick"}
}
, "questionFirstAnswered" : [{"_value" : "2022-10-27T11:58:40.273Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2022-10-20", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Voluntary Scheme for Branded Medicines Pricing and Access"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, what recent assessment he has made of the potential impact of changes in the 2019 Voluntary Scheme for Branded Medicines Pricing and Access rebate rate on foreign direct investment into UK life science R&D.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4124", "label" : {"_value" : "Biography information for Chi Onwurah"}
}
, "tablingMemberConstituency" : {"_value" : "Newcastle upon Tyne Central"}
, "tablingMemberPrinted" : [{"_value" : "Chi Onwurah"}
], "uin" : "67898"}
, {"_about" : "http://data.parliament.uk/resources/1524731", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1524731/answer", "answerText" : {"_value" : "
The Department\u2019s Ministerial meetings are published on GOV.UK at the following link:<\/p>
<\/p>
https://www.gov.uk/government/collections/ministerial-gifts-hospitality-overseas-travel-and-meetings#2022<\/a><\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4423", "label" : {"_value" : "Biography information for Will Quince"}
}
, "answeringMemberConstituency" : {"_value" : "Colchester"}
, "answeringMemberPrinted" : {"_value" : "Will Quince"}
, "dateOfAnswer" : {"_value" : "2022-11-01", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "previousAnswerVersion" : {"_about" : "http://data.parliament.uk/resources/1524731/answer/previousversion/27496", "answeringMember" : "http://data.parliament.uk/members/4320", "answeringMemberConstituency" : {"_value" : "Newark"}
, "answeringMemberPrinted" : {"_value" : "Robert Jenrick"}
}
, "questionFirstAnswered" : [{"_value" : "2022-11-01T12:01:27.627Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2022-10-20", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Voluntary Scheme for Branded Medicines Pricing and Access"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, what recent discussions she has with representatives of (a) pharmaceutical and (b) life science companies on changes in the 2019 Voluntary Scheme for Branded Medicines Pricing and Access rebate rate.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4124", "label" : {"_value" : "Biography information for Chi Onwurah"}
}
, "tablingMemberConstituency" : {"_value" : "Newcastle upon Tyne Central"}
, "tablingMemberPrinted" : [{"_value" : "Chi Onwurah"}
], "uin" : "67899"}
, {"_about" : "http://data.parliament.uk/resources/1523884", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1523884/answer", "answerText" : {"_value" : "This information is not held in the format requested.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4423", "label" : {"_value" : "Biography information for Will Quince"}
}
, "answeringMemberConstituency" : {"_value" : "Colchester"}
, "answeringMemberPrinted" : {"_value" : "Will Quince"}
, "dateOfAnswer" : {"_value" : "2022-10-27", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "previousAnswerVersion" : {"_about" : "http://data.parliament.uk/resources/1523884/answer/previousversion/26731", "answeringMember" : "http://data.parliament.uk/members/4320", "answeringMemberConstituency" : {"_value" : "Newark"}
, "answeringMemberPrinted" : {"_value" : "Robert Jenrick"}
}
, "questionFirstAnswered" : [{"_value" : "2022-10-27T13:13:41.45Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2022-10-18", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Gastrointestinal System: Surgery"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 22 September 2022 to Question 49137 on Gastrointestinal System: Surgery, whether her Department has made an estimate of the number of patients living with (a) colostomy, (b) ileostomy and (c) urostomy following their operation.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4124", "label" : {"_value" : "Biography information for Chi Onwurah"}
}
, "tablingMemberConstituency" : {"_value" : "Newcastle upon Tyne Central"}
, "tablingMemberPrinted" : [{"_value" : "Chi Onwurah"}
], "uin" : "65758"}
, {"_about" : "http://data.parliament.uk/resources/1523886", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1523886/answer", "answerText" : {"_value" : "
On 3 February 2022, the Medicines and Healthcare products Regulatory Agency approved Nuvaxovid for use as a COVID-19 primary course vaccination. The Government accepted advice from the Joint Committee on Vaccination and Immunisation (JCVI) that in exceptional circumstances, Nuvaxovid may be used when no clinically suitable United Kingdom-approved COVID-19 vaccine alternative is available. The JCVI\u2019s advice allows its use in either COVID-19 primary course vaccination or off-label as a COVID-19 booster dose. In line with the JCVI\u2019s advice, the Nuvaxovid vaccine is the current alternative for those who are clinically intolerant to and are unable to receive the COVID-19 mRNA vaccines manufactured by Pfizer and Moderna. Deployment of Nuvaxovid began on 28 September 2022.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4679", "label" : {"_value" : "Biography information for Neil O'Brien"}
}
, "answeringMemberConstituency" : {"_value" : "Harborough"}
, "answeringMemberPrinted" : {"_value" : "Neil O'Brien"}
, "dateOfAnswer" : {"_value" : "2022-11-03", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "previousAnswerVersion" : {"_about" : "http://data.parliament.uk/resources/1523886/answer/previousversion/25935", "answeringMember" : "http://data.parliament.uk/members/4592", "answeringMemberConstituency" : {"_value" : "Sleaford and North Hykeham"}
, "answeringMemberPrinted" : {"_value" : "Dr Caroline Johnson"}
}
, "questionFirstAnswered" : [{"_value" : "2022-11-03T16:11:36.153Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2022-10-18", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Coronavirus: Vaccination"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, with reference to the regulatory approval of covid-19 vaccine Nuvaxovid, what plans she has for the usage of this vaccine as (a) a covid-19 booster vaccination or (b) other uses.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4124", "label" : {"_value" : "Biography information for Chi Onwurah"}
}
, "tablingMemberConstituency" : {"_value" : "Newcastle upon Tyne Central"}
, "tablingMemberPrinted" : [{"_value" : "Chi Onwurah"}
], "uin" : "65759"}
], "itemsPerPage" : 10, "next" : "http://eldaddp.azurewebsites.net/answeredquestions.text?_page=1&min-date=2021-05-27&AnsweringBody.=Department+of+Health+and+Social+Care&min-answer.questionFirstAnswered.=2019-05-20T16%3A45%3A48.73Z&tablingMemberConstituency=Newcastle+upon+Tyne+Central&max-answer.dateOfAnswer=2022-11-03", "page" : 0, "startIndex" : 1, "totalResults" : 122, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]}
}